Journals / Van Tıp Dergisi / 2015 / Cilt: 22 - Sayı: 3

Does Desnutrin Have A Role in The Pathogenesis of Gestational Diabetes Mellitus?

Gestasyonel Diyabetes Mellitus Patogenezinde Desnutrin'in Rolü Varmı?

Pages
144–148
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Although this decrease is not statistically significant (p > 0.05), desnutrin may play role in the etiology of GDM.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gestational diabetes (GDM) is diabetes that occurs during pregnancy.
📊
Key Findings & Data:This increase in insulin resistance in non-diabetic pregnant women is thought to be compansated by various adaptation mechanisms.
💡
Conclusion & Impact:Conclusion: Although this decrease is not statistically significant (p > 0.05), desnutrin may play role in the etiology of GDM.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Gestational diabetes (GDM) is diabetes that occurs during pregnancy. Pregnancy is characterized by insulin resistance. This increase in insulin resistance in non-diabetic pregnant women is thought to be compansated by various adaptation mechanisms. It is thought that this adaptation is not enough response so gestational diabetes can develop. Desnutrin is a lipolytic protein that has role in the regulation of lipolysis in adipose tissue. It is known that there is a clear correlation between adipocyte triacylglycerol (TAG) lipolysis disruption and disorders such as type 2 diabetes mellitus (DM), obesity, insulin resistance and serum free fatty acids. Methods: In this study; serum desnutrin levels of healthy pregnant women and patients with GDM were compared and the role of desnutrin in the pathogenesis of GDM was investigated. Results: In our study; desnutrin levels of GDM group were lower than those in control group. Conclusion: Although this decrease is not statistically significant (p > 0.05), desnutrin may play role in the etiology of GDM.

Özet

Amaç: Gestasyonel diyabetes mellitus (GDM), gebelikte meydana gelen diyabettir. Gebelik insülin direnci ile karakterizedir. Diyabetik olmayan gebelerde insülin direncindeki bu artış çeşitli adaptasyon mekanizmalarıyla dengelenmektedir. Bu adaptasyona yanıt yeterli olmazsa gestasyonel diyabetes mellitus gelişebileceği yönünde fikirler ortaya konmuştur. Desnutrin adipoz dokudaki lipolizin düzenlenmesinde rol oynayan lipolitik bir proteindir. Adipositlerde triaçilgliserol lipolizinin bozulmasıyla tip 2 diyabetes mellitus (DM), obezite, insülin direnci ve serum serbest yağ asitleri arasında açık bir ilişki olduğu bilinmektedir. Yöntem: Bu çalışmada; sağlıklı gebeler ile GDM’lu olgular arasındaki plazma desnutrin düzeyleri karşılaştırılmış ve GDM etyopatogenezinde desnutrinin rolü araştırılmıştır. Bulgular: Çalışmamızda; desnutrin düzeyi GDM’lu grupta normal gruba göre düşük bulunmuştur. Sonuç: Bu azalma istatistiksel olarak anlamlı olmasa da (p>0.05) desnutrinin, GDM’nin etyopatolojisinde rol oynadığını düşündürmektedir.

🔖

Cite This Article

ATLI, H. G., ATILGAN, R., ATLI, H., GÜREL, A., AYDIN, S. (2015). Does Desnutrin Have A Role in The Pathogenesis of Gestational Diabetes Mellitus?. Van Tıp Dergisi, Cilt: 22 - Sayı: 3, 144–148. https://ajindex.com/articles/334075

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Report of the Expert Committe (editorial). Diagnonosis and Classification of Diabetes mellitus. Diabetes Care 2003; 26: 5- 20
  2. Aşıcı N. Gestasyonel Diyabetes Mellituslu Hastaların Tedavisinde Glyburide Kullanılması ve Sonuçların İnsulinle Tedavi edilen Hastaların sonuçları İle Karşılaştırılması. Uzmanlık tezi, İstanbul: Sağlık Bakanlığı Süleymaniye Doğum ve Kadın hastalıkları Hastanesi, 2005
  3. Sheffield JS. Gestational diabetes; Effects of the degree of hyperglycemia and the gesational age at diagnosis. Soc Gyn Inv 1999; 6: 6- 7
  4. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, et al. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 2006; 281(52):40236-40241
  5. Herrera E, Lasunción MA, Palacín M, Zorzano A, Bonet B. Intermediary metabolism in pregnancy. First theme of the Freinkel era. Diabetes 1991; 40 Suppl 2:83-88
  6. Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003; 101(2):380-392
  7. Kühl C. Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes 1991; 40 Suppl 2:18-24
  8. Sorenson RL, Brelje TC, Roth C. Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 1993; 133(5):2227- 2234
  9. Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 1992; 130(3):1459- 1466
  10. Nadal A, Alonso-Magdalena P, Soriano S, Ropero AB, Quesada I. The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 2009; 587(Pt 21):5031-5037
  11. Damm P, Kühl C, Hornnes P, Mølsted-Pedersen L. A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care 1995; 18(5):654-665
  12. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, et al. Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol 2005; 240(1-2):43-49
  13. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hyper